森赫股份(301056.SZ):兩個募投項目延期
格隆匯9月7日丨森赫股份(301056.SZ)公佈,公司於2022年9月6日召開了第四屆董事會第四次會議和第四屆監事會第四次會議,審議通過了《關於部分募集資金投資項目延期的議案》,同意公司在募集資金投資項目實施主體、實施方式、募集資金投資用途及投資規模不發生變更的前提下,結合目前募投項目的實際進展情況,將“電梯智能製造生產線建設項目”和“企業技術中心升級建設項目”兩個募投項目的預定可使用狀態日期調整為自項目建設起36個月。本次部分募投項目延期不涉及變更募集資金的用途及實施方式,不會對公司正常的生產經營和業務發展產生不利影響。本次部分募投項目延期在董事會的審批權限範圍內,無需提交股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.